SGLT2 inhibitor (empagliflozin) given in a lupus mouse (MRL/lpr) model showed a renoprotective effect suggesting the value of non-immunosuppressive therapies to improve renal function. Showed less -dsDNA Abs, proteinuria, renal nephritis damage https://t.co/VfLUbCjmMt https://t.co/EAsvfzRgm1
Links:
SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing in…
https://bit.ly/3RQmyVi
Dec-19-2023
